Surrogate end points in heart failure
- 25 April 2002
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (9) , 1414-1421
- https://doi.org/10.1016/s0735-1097(02)01773-4
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failurePublished by Elsevier ,2004
- Left ventricular volume in thrombolysed patients with acute anterior myocardial infarction: the effect of captopril and xamoterolInternational Journal of Cardiology, 1995
- Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the framingham heart study)The American Journal of Cardiology, 1992
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendanAmerican Heart Journal, 1992
- The prognostic value of exercise capacity: A review of the literatureAmerican Heart Journal, 1991
- Factors influencing the one-year mortality of dilated cardiomyopathyThe American Journal of Cardiology, 1984
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.Circulation, 1982
- Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.Circulation, 1979
- Ventricular Premature Beats and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1977